Noun
a Cox-2 inhibitor (trade name Vioxx) that relieves pain and inflammation without harming the digestive tract; voluntarily withdrawn from the market in 2004
Source: WordNetFurther data, from the APPROVe trial, showed a statistically significant relative risk of cardiovascular events of 1.97 versus placebo citation —which caused a worldwide withdrawal of rofecoxib in October 2004. Source: Internet
A statistically significant increase in the incidence of myocardial infarctions was observed in patients on rofecoxib. Source: Internet